Japanese surgeon whose JCOG trials defined D2 gastrectomy and adjuvant S-1 as standards for gastric cancer.
Mitsuru Sasako (Tokyo and Hyogo) led the JCOG 9501 trial showing that extended para-aortic nodal dissection adds nothing to D2 gastrectomy, and co-led the ACTS-GC trial that established adjuvant S-1 after D2 surgery in Japan. His surgical standards and training work underpin the D2 approach now recommended in Western guidelines. He remains an advisor to international gastric cancer surgical trials.
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, surgery.
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, surgery.
Shares Gastric & gastro-oesophageal junction cancer and the tag gastric.
Shares Gastrectomy, Gastric & gastro-oesophageal junction cancer.
Shares Gastric & gastro-oesophageal junction cancer and the tag gastric.
Shares Gastrectomy, Gastric & gastro-oesophageal junction cancer.
Shares Gastric & gastro-oesophageal junction cancer and the tag gastric.
Shares Gastric & gastro-oesophageal junction cancer and the tag gastric.